No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1018 |
4. Check minimum number of eventsNone |
1018 |
5. Include endpointsNone |
1018 |
6. Filter based on genotype QC (FinnGen only) |
919 |
Control definitions (FinnGen only)
- Control exclude
- AB1_MYCOSES
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Other superficial mycoses
based on the number of shared cases.
Similar with more cases:
- Other superficial mycoses, including avohilmo
- Mycoses
- Mycoses, including avohilmo
- Certain infectious and parasitic diseases
- Certain infectious and parasitic diseases, including avohilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5932 | 2806 | 3076 |
| Only index persons | 5363 | 2569 | 2794 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.08 | 0.09 |
| Only index persons | 0.10 | 0.09 | 0.11 |
| Median age at first event (years) | |||
| Whole population | 38.43 | 39.96 | 37.05 |
| Only index persons | 37.82 | 39.40 | 36.37 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 919 | 485 | 434 |
| Unadjusted period prevalence (%) | 0.18 | 0.17 | 0.20 |
| Median age at first event (years) | 46.02 | 43.36 | 48.98 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 957
- Matched controls
- 9570
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B36.0
ICD-10 Finland
Pityriasis versicolor
422.6
307.7
711
65
B36.8
ICD-10 Finland
Other specified superficial mycoses
61.2
112.7
63
11
B36.9
ICD-10 Finland
Superficial mycosis, unspecified
52.0
93.5
54
11
J02AC02
ATC
itraconazole; systemic
3.7
68.4
279
952
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
3.4
66.0
332
1292
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.6
55.6
147
363
J02AB02
ATC
ketoconazole; oral
7.1
47.3
74
112
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.8
41.8
290
1304
H62.2*B36.9
ICD-10 Finland
Otomycosis NOS
+∞
34.6
33
*
XQ848
NOMESCO Finland
Dermatological photography
6.1
33.5
60
104
E0000UV, ,
ATC
2.2
31.9
467
2868
B36
ICD-10 Finland
Other superficial mycoses
36.3
27.6
35
10
L04AX03
ATC
methotrexate; systemic
2.8
24.0
130
503
L04AA01
ATC
[U] ciclosporin
9.6
23.6
28
30
11100
ICD-8 Finland
Dermatomycosis, other and unspecified, Pityriasis versicolor
+∞
22.0
21
*
127
Kela drug reimbursment
Transplant complication
6.6
21.5
35
55
D07AC01
ATC
betamethasone; topical
1.9
19.8
369
2362
B35.3
ICD-10 Finland
Tinea pedis
3.7
19.2
62
175
L04AA06
ATC
mycophenolic acid; systemic
5.4
19.0
38
73
L04AX01
ATC
azathioprine; systemic
3.8
18.9
60
167
D01AC02
ATC
miconazole; topical
2.9
17.7
85
307
J02AC01
ATC
fluconazole; systemic
1.8
17.6
383
2555
Z94.0
ICD-10 Finland
Kidney transplant status
7.9
17.5
24
31
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.6
17.4
59
172
L04AD01
ATC
ciclosporin; systemic
5.6
17.2
33
61
11199
ICD-8 Finland
Dermatomycosis, other and unspecified, Unspecified
+∞
16.7
16
*
TQW80
NOMESCO Finland
Local dermatologic skincare
4.5
16.5
40
91
L04AD02
ATC
tacrolimus; systemic
6.7
16.3
26
40
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
16.2
421
2940
L01BA01
ATC
methotrexate; systemic
4.0
16.1
46
119
D01BA02
ATC
terbinafine; oral
1.9
16.0
248
1476
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.4
15.7
119
539
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
6.3
15.5
26
42
D01AE15
ATC
terbinafine; topical
2.8
15.2
79
297
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.9
14.7
73
268
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
14.7
186
1031
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
3.7
14.5
47
133
D07AD01
ATC
clobetasol; topical
2.0
13.7
162
874
XQ845
NOMESCO Finland
Dermatoscopy
5.2
13.7
28
55
J01FF01
ATC
clindamycin; systemic
1.8
13.6
258
1627
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.9
13.1
29
61
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.3
13.1
105
487
L04AB04
ATC
adalimumab; parenteral
3.8
13.0
40
109
B35.6
ICD-10 Finland
Tinea inguinalis [Tinea cruris]
4.3
12.8
33
79
D07AC13
ATC
mometasone; topical
1.7
12.6
273
1784
1110A
ICD-9 Finland
Dermatomycosis, other and unspecified, Pityriasis versicolor
+∞
12.5
12
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
12.3
133
694
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
12.2
243
1546
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
5.0
12.2
26
53
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.3
12.2
101
474
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.9
12.1
56
198
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
3.4
12.0
43
130
N02AX02
ATC
tramadol; systemic, rectal
1.6
11.8
384
2781
D02AE01
ATC
carbamide; topical
2.7
11.8
67
264
J01DB01
ATC
cefalexin; oral
1.8
11.5
794
6937
B07.9
ICD-10 Finland
Verruca simplex
3.0
10.7
48
167
TK800
NOMESCO Finland
Hemodialysis
4.2
10.7
28
68
B35.1
ICD-10 Finland
Tinea unguium
2.4
10.5
72
311
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
10.5
210
1333
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.2
10.5
28
69
H02AB06
ATC
prednisolone; systemic
1.6
10.5
418
3157
A07EC01
ATC
sulfasalazine; oral, rectal
2.3
10.4
83
383
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.5
10.4
35
102
H02AB04
ATC
methylprednisolone; systemic
2.0
10.3
127
692
B35.4
ICD-10 Finland
Tinea corporis
5.0
10.3
22
45
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
10.2
174
1053
J01MA02
ATC
ciprofloxacin; systemic
1.6
10.1
318
2266
A02BC02
ATC
pantoprazole; systemic
1.6
10.0
604
4987
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.8
9.9
179
1102
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.7
9.9
54
209
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.3
9.6
74
337
XQ802
NOMESCO Finland
Epicutan test
2.8
9.5
48
178
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.6
9.5
55
219
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
9.4
239
1613
D01AE16
ATC
amorolfine; topical
2.1
9.4
95
483
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
8.1
9.4
20
25
XG410
NOMESCO Finland
Flow-volume spirometry
3.0
9.3
41
141
XQ800
NOMESCO Finland
Prick test
2.2
9.3
80
382
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
9.1
345
2554
D01AC03
ATC
econazole; topical
2.5
9.0
57
238
C08CA02
ATC
felodipine; oral
2.3
8.8
67
303
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
8.8
85
424
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
8.8
270
1902
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
4.2
8.8
23
56
R03DC03
ATC
montelukast; oral
1.7
8.7
166
1035
UKC02
NOMESCO Finland
Cystoscopy
1.9
8.7
118
664
N18.8
ICD-10 Finland
Other chronic renal failure
4.3
8.7
22
52
D07XC01
ATC
betamethasone; topical
1.9
8.7
111
613
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.1
8.6
81
400
L73.8
ICD-10 Finland
Other specified follicular disorders
4.8
8.6
19
40
L17
ICPC
Foot/toe symptom/complaint
1.6
8.6
273
1937
XKD00
NOMESCO Finland
Uroflowmetry
1.9
8.5
113
631
S29
ICPC
Skin symptom/complaint other
1.7
8.5
183
1179
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.8
8.5
129
753
WZC00
NOMESCO Finland
Treatment plan or consultation
1.5
8.4
346
2599
N05CF01
ATC
zopiclone; oral
1.6
8.3
256
1802
ZXC50
NOMESCO Finland
Cryotherapy
3.5
8.3
28
82
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.0
8.2
97
522
A01AB09
ATC
miconazole; local oral
2.2
8.2
72
347
L04AA11
ATC
[U] etanercept
17.3
8.1
12
7
L71.8
ICD-10 Finland
Other rosacea
4.2
8.0
21
51
R03BB04
ATC
tiotropium bromide; inhalant
2.1
8.0
77
384
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.1
8.0
78
391
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
8.0
390
3026
L30.0
ICD-10 Finland
Nummular dermatitis
2.6
7.8
43
168
SPAT1263
SPAT
Sampling
1.5
7.8
361
2769
L88
ICPC
Rheumatoid/seropositive arthritis
2.7
7.7
40
151
B37.08
ICD-10 Finland
Other candidal stomatitis
15.2
7.7
12
8
S06
ICPC
Rash localized
2.4
7.7
54
236
UJF92
NOMESCO Finland
Capsular endoscopy
3.4
7.7
27
81
R03AC02
ATC
salbutamol; inhalant
1.5
7.7
511
4201
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
7.6
99
549
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.4
7.6
50
213
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
7.5
155
985
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.9
7.5
98
544
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
4.3
7.5
19
45
E000001, ,
ATC
1.6
7.5
180
1192
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
4.0
7.5
21
54
H02AB09
ATC
hydrocortisone; systemic
3.4
7.4
26
78
R06AE07
ATC
cetirizine; oral
1.5
7.4
402
3170
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.8
7.4
36
132
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
7.3
389
3052
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.9
7.3
94
519
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
7.3
109
632
11180
ICD-8 Finland
Dermatomycosis, other and unspecified, Erythrasma mycoides
+∞
7.3
7
*
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
4.5
7.2
17
38
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
7.2
200
1371
A02BC01
ATC
omeprazole; systemic
1.6
7.1
215
1499
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
3.4
7.1
25
75
P01BA02
ATC
hydroxychloroquine; oral
2.0
7.1
72
366
M25.5
ICD-10 Finland
Pain in joint
1.5
7.1
310
2339
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
7.1
129
793
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
7.0
217
1521
UJF32
NOMESCO Finland
Coloscopy
1.6
7.0
195
1334
A02BC05
ATC
esomeprazole; systemic
1.5
7.0
334
2563
J01MA12
ATC
levofloxacin; systemic
1.7
7.0
139
876
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
3.2
6.9
26
82
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.7
6.9
36
137
Z00.8
ICD-10 Finland
Other general examinations
1.9
6.7
84
460
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
6.6
104
613
N28
ICPC
Limited function/disability (N)
4.2
6.6
17
41
D09AB01
ATC
zinc bandage without supplements; topical
4.2
6.6
17
41
C07AB07
ATC
bisoprolol; oral
1.4
6.6
341
2652
L43.9
ICD-10 Finland
Lichen planus, unspecified
3.9
6.6
19
50
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
6.5
73
385
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.4
6.5
42
177
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
6.5
183
1254
R50.9
ICD-10 Finland
Fever, unspecified
1.7
6.5
139
891
S02
ICPC
Pruritus
2.5
6.5
39
159
D07BC01
ATC
betamethasone and antiseptics; topical
1.8
6.5
98
570
L40.5
ICD-10 Finland
Arthropathic psoriasis
3.7
6.5
20
55
N03AX16
ATC
[U] pregabalin
1.6
6.4
182
1249
L28
ICPC
Limited function/disability (L)
1.7
6.4
123
766
D05AX52
ATC
calcipotriol, combinations; topical
2.3
6.4
49
223
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prosthodontic work
2.6
6.4
36
142
L30.3
ICD-10 Finland
Infective dermatitis
2.5
6.4
38
154
R06.0
ICD-10 Finland
Dyspnoea
1.5
6.4
214
1523
Z3226
NOMESCO Finland
Physiotherapist
1.6
6.4
147
960
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
6.4
177
1209
J45.1
ICD-10 Finland
Nonallergic asthma
2.1
6.4
63
318
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.8
6.4
91
521
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.2
6.4
54
257
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
6.6
6.3
15
23
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.1
6.3
55
264
A07AA02
ATC
nystatin; oral
2.4
6.3
42
180
H02AB07
ATC
prednisone; oral
1.8
6.3
105
629
E000007, ,
ATC
2.1
6.3
58
285
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.0
6.3
62
313
L04AA17
ATC
[U] adalimumab
18.1
6.3
9
5
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
2.0
6.2
67
350
R60.0
ICD-10 Finland
Localized oedema
1.8
6.2
93
541
S18
ICPC
Laceration/cut
1.4
6.1
393
3164
S97
ICPC
Chronic ulcer skin
2.2
6.1
48
221
N06AB04
ATC
citalopram; systemic
1.6
6.1
168
1144
M79.6
ICD-10 Finland
Pain in limb
1.4
6.1
381
3052
WX892
NOMESCO Finland
Monitored bed care
2.0
6.1
63
323
L70.0
ICD-10 Finland
Acne vulgaris
2.5
6.1
37
152
R60.9
ICD-10 Finland
Oedema, unspecified
2.3
6.1
44
196
A11CC03
ATC
alfacalcidol; systemic
3.1
6.1
24
78
H60.3
ICD-10 Finland
Other infective otitis externa
2.8
6.1
30
111
N02BE01
ATC
paracetamol; systemic, rectal
1.6
6.0
812
7461
L03.9
ICD-10 Finland
Cellulitis, unspecified
3.3
6.0
22
68
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
636
4758
2.00
22.14
15.1
9.9
4.09
4.04
e9/l
0.20
570
4150
752
6119
2.07
18.78
12.1
8.1
75.84
77.23
u/l
0.35
727
5837
213
1189
2.02
16.67
2.7
1.9
—
—
—
0
0
458
3285
1.76
15.99
7.3
5.2
36.42
36.59
g/l
0.27
433
3118
491
3700
1.67
13.47
11.5
7.6
1.21
1.21
mmol/l
0.01
433
3224
36
90
4.12
13.18
1.5
1.3
—
—
—
0
0
716
5985
1.78
13.17
7.6
4.1
10.94
10.00
mm/h
1.08
687
5647
56
200
2.91
11.88
11.3
6.7
236.60
409.88
iu/ml
—
10
24
206
1263
1.80
11.72
3.6
2.5
12.76
14.07
umol/l
1.86
198
1194
125
652
2.05
11.54
1.5
1.3
178.64
206.97
u/ml
0.24
118
607
438
3297
1.61
11.41
10.6
7.1
1.21
1.21
mmol/l
0.21
406
3073
630
5183
1.63
11.25
6.0
4.1
349.86
321.41
e6/l
—
7
69
94
446
2.23
11.06
3.9
3.0
181.65
164.55
ng/l
0.19
80
392
74
317
2.45
10.99
1.8
1.5
2.69
0.05
iu/ml
0.96
14
51
178
1071
1.81
10.70
3.6
2.6
22.17
23.97
%
1.08
172
1019
433
3293
1.58
10.53
12.5
11.2
1.17
1.17
inr
0.10
377
2721
104
525
2.10
10.46
2.5
1.7
—
—
—
0
0
468
3636
1.56
10.28
3.3
2.5
74.38
74.38
nmol/l
0.00
436
3354
126
688
1.96
10.20
3.6
2.7
10.48
10.68
g/l
0.22
116
642
133
740
1.93
10.19
8.3
11.0
94.88
95.85
%
0.79
128
719
547
4410
1.56
10.13
5.1
3.4
0.00
0.36
estimate
0.52
102
856
519
4143
1.55
9.99
8.5
6.8
10.86
11.26
umol/l
0.45
489
3962
343
2496
1.58
9.95
4.6
3.2
23.19
66.93
e6/l
0.96
266
1850
278
1932
1.62
9.74
1.6
1.4
2.33
2.34
g/l
0.02
180
1249
247
1671
1.64
9.63
4.4
2.6
3.86
6.05
e6/l
2.51
227
1506
537
4340
1.54
9.62
5.0
3.4
0.00
0.00
estimate
0.50
110
904
340
2494
1.56
9.41
4.2
2.7
55.74
61.61
u/l
1.18
315
2338
186
1179
1.72
9.24
3.6
2.5
2.35
2.36
g/l
0.16
176
1104
100
521
2.03
9.23
2.3
2.3
11.29
7.83
ug/l
0.32
91
474
538
4378
1.52
9.13
5.1
3.4
0.00
6.92
estimate
1.34
113
909
559
4597
1.52
8.94
7.6
5.4
6.59
6.59
mmol/l
0.01
533
4305
316
2306
1.55
8.83
3.4
2.1
154.43
257.49
u/l
1.66
302
2205
98
516
2.00
8.78
6.8
4.3
108.73
83.29
ng/l
0.91
91
465
137
812
1.80
8.56
8.4
10.5
0.60
0.75
mmol/l
0.19
119
684
61
269
2.35
8.53
3.0
1.8
—
—
—
0
0
28
83
3.45
8.12
2.1
1.7
—
—
—
0
0
286
2073
1.54
8.12
3.8
2.7
348.74
341.43
umol/l
0.55
259
1875
140
849
1.76
8.08
2.7
2.1
368.91
374.10
nmol/l
0.07
124
794
263
1875
1.56
8.03
4.1
3.2
1448.08
949.94
ng/l
1.01
234
1570
294
2150
1.53
7.99
4.1
3.0
0.44
0.37
e6/l
0.19
213
1514
188
1240
1.64
7.95
3.5
2.7
126.76
101.10
ug/g
0.56
154
997
385
2986
1.48
7.85
4.5
3.5
31.51
32.24
u/l
0.19
370
2841
513
4211
1.47
7.82
3.9
3.1
113.54
108.62
ug/l
0.24
484
3998
57
254
2.32
7.80
2.8
1.7
—
—
—
0
0
195
1307
1.62
7.71
6.6
3.6
0.81
0.82
mmol/l
0.49
187
1250
835
7626
1.74
7.61
6.0
5.0
1.79
1.83
mu/l
0.37
787
7195
727
6425
1.55
7.53
5.0
4.2
14.63
14.55
pmol/l
0.42
675
5998
141
876
1.71
7.45
2.6
1.8
—
—
—
0
0
206
1414
1.58
7.35
5.2
3.5
184.99
613.86
ng/l
1.99
140
977
264
1924
1.51
7.17
5.4
3.4
1.02
1.02
kg/l
0.67
181
1270
66
326
2.10
7.05
2.4
1.8
—
—
—
0
0
73
376
2.02
6.97
2.3
2.0
7.50
6.67
iu/ml
0.09
18
84
95
536
1.86
6.95
2.6
3.8
4.42
4.62
pmol/l
1.38
81
487
134
840
1.69
6.84
2.6
1.9
—
—
—
0
0
690
6082
1.48
6.77
3.6
3.4
—
—
—
0
0
348
2709
1.45
6.69
4.5
3.5
7.71
8.37
mmol/l
1.85
298
2347
116
703
1.74
6.69
6.1
4.0
2.00
1.63
mmol/l
0.53
101
597
192
1325
1.56
6.64
3.2
2.7
0.67
1.00
e6/l
1.20
101
652
55
259
2.19
6.64
1.4
1.2
2.33
10.29
u/ml
—
9
38
101
591
1.79
6.57
1.7
1.5
—
—
—
0
0
72
378
1.98
6.53
3.1
2.2
35.90
38.60
u/l
0.71
65
346
87
488
1.86
6.48
9.1
12.7
1.13
1.30
%
1.26
87
483
361
2843
1.43
6.47
4.2
3.3
46.78
38.96
ng/l
0.18
218
1755
24
75
3.26
6.45
2.3
1.8
—
—
—
0
0
268
2001
1.47
6.35
2.6
2.2
2.74
2.72
mg/l
0.04
236
1737
406
3281
1.41
6.24
2.2
2.0
94.68
95.74
pmol/l
0.17
232
1802
81
453
1.86
6.10
9.2
13.0
23.87
24.34
mmol/l
0.61
81
447
273
2064
1.45
6.01
1.7
1.6
18.86
20.37
nmol/l
1.08
238
1787
76
419
1.88
5.98
4.9
3.7
1.84
1.76
mmol/l
0.06
43
299
92
540
1.78
5.93
3.3
2.9
67.06
67.52
g/l
0.28
87
512
328
2574
1.42
5.87
3.8
3.4
2.35
2.35
mmol/l
0.32
299
2382
257
1929
1.45
5.86
2.1
1.8
0.81
1.10
mg/l
2.12
192
1448
287
2204
1.43
5.78
1.4
1.3
1.94
1.75
u/ml
0.05
69
627
113
711
1.67
5.68
2.5
2.7
0.22
0.22
g/l
0.13
104
673
109
680
1.68
5.66
1.3
1.2
95.23
148.63
u/ml
1.10
39
278
43
196
2.25
5.64
1.6
1.3
—
—
—
0
0
406
3328
1.38
5.54
4.9
3.2
0.02
0.02
estimate
0.02
97
753
10
10
10.09
5.54
4.0
2.6
—
—
—
0
0
21
67
3.18
5.49
1.9
1.3
9276.57
16855.33
e6/l
0.45
14
46
874
8217
1.73
5.47
24.3
13.7
18.95
22.18
mg/l
3.02
750
6651
27
100
2.75
5.47
3.4
1.6
—
—
—
0
0
222
1643
1.46
5.40
1.4
1.3
27.89
29.23
iu/ml
0.06
76
485
816
7563
1.54
5.22
6.9
5.6
38.86
38.46
mmol/mol
0.60
781
7212
296
2324
1.40
5.16
5.8
3.5
0.00
0.01
estimate
1.34
106
850
174
1238
1.50
5.15
3.0
2.9
3.51
2.41
e6/l
0.59
80
569
40
186
2.20
5.03
2.0
1.6
16827.72
8996.23
e6/l
0.44
32
137
256
1973
1.41
4.94
2.5
2.3
—
—
—
0
0
21
73
2.92
4.78
3.5
3.6
—
—
—
0
0
30
126
2.43
4.76
1.1
1.4
—
—
—
0
0
30
126
2.43
4.76
1.1
1.4
—
—
—
0
0
34
152
2.28
4.71
1.9
1.5
—
—
—
0
0
144
1005
1.51
4.66
13.2
6.6
1.07
1.03
mmol/l
0.95
137
952
18
58
3.14
4.65
2.0
2.6
725.00
481.98
e6/l
0.56
12
46
46
234
2.01
4.62
4.2
2.6
—
—
—
0
0
38
180
2.16
4.59
3.1
1.5
—
—
—
0
0
43
214
2.06
4.58
3.2
1.6
—
—
—
0
0
28
117
2.44
4.51
1.2
1.2
—
—
—
0
0
203
1527
1.42
4.45
1.5
1.3
15.96
11.04
u/ml
0.37
76
616
43
218
2.02
4.37
1.1
1.2
26.20
54.67
u/ml
—
7
22
51
275
1.90
4.35
3.1
1.9
2.69
2.26
ug/l
0.12
45
253
19
66
2.92
4.35
1.9
1.5
—
—
—
0
0
19
66
2.92
4.35
1.9
1.5
—
—
—
0
0
19
66
2.92
4.35
1.9
1.5
—
—
—
0
0
32
145
2.25
4.32
3.2
1.5
—
—
—
0
0
297
2394
1.35
4.26
5.3
4.3
9.15
9.02
mg/mmol
0.02
198
1515
138
973
1.49
4.25
3.1
3.0
6.20
7.47
umol/l
0.73
113
870
95
618
1.60
4.21
2.9
2.4
16.59
18.50
au/ml
—
10
75
24
97
2.51
4.15
1.2
1.1
—
—
—
0
0
29
129
2.29
4.09
3.7
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
196
2.03
4.08
2.2
3.2
0.20
0.35
iu/ml
2.57
18
98
33
156
2.16
4.04
2.4
1.5
—
—
—
0
0
17
58
2.97
4.02
2.1
2.7
169.36
232.38
e6/l
0.60
11
50
14
36
3.93
4.00
1.9
1.5
1.81
1.99
umol/l
0.43
14
30
24
99
2.46
3.99
1.8
1.4
—
—
—
0
0
16
53
3.05
3.98
2.8
2.8
—
—
—
0
0
906
8704
1.77
3.89
17.7
11.1
28.30
27.69
u/l
0.34
892
8516
255
2033
1.35
3.88
1.8
1.6
—
—
—
0
0
860
8167
1.52
3.79
25.1
15.6
3.97
3.95
mmol/l
1.28
843
8012
6
5
12.06
3.76
1.2
1.0
—
—
—
0
0
11
24
4.62
3.75
4.3
4.3
—
—
—
0
0
834
7877
1.46
3.72
19.8
12.7
87.39
88.29
ml/min/173m2
0.57
794
7217
14
39
3.63
3.71
1.5
1.5
21.47
28.53
umol/l
1.85
14
34
39
204
1.95
3.67
3.4
1.6
—
—
—
0
0
23
97
2.40
3.67
1.8
1.4
—
—
—
0
0
26
116
2.28
3.67
2.8
1.5
—
—
—
0
0
443
3836
1.29
3.65
3.1
2.7
—
—
estimate
—
0
0
857
8149
1.49
3.57
24.9
15.4
139.54
139.67
mmol/l
0.97
844
8011
21
86
2.47
3.57
1.1
1.1
—
—
—
0
0
20
80
2.53
3.56
1.1
1.1
—
—
—
0
0
23
99
2.36
3.52
1.8
1.4
—
—
—
0
0
30
145
2.10
3.50
1.3
1.1
—
—
—
0
0
76
491
1.60
3.49
2.8
2.3
6051.12
5144.10
u/l
0.08
31
212
38
201
1.93
3.48
2.2
1.5
157.93
150.31
au/ml
0.18
14
62
20
81
2.50
3.48
1.1
1.1
—
—
—
0
0
44
245
1.83
3.45
1.6
1.3
—
—
—
0
0
30
146
2.09
3.45
1.4
1.1
0.52
2.21
—
6
31
41
226
1.85
3.33
1.6
1.3
265.31
218.97
u/ml
0.36
29
139
20
83
2.44
3.32
1.1
1.1
—
—
—
0
0
20
83
2.44
3.32
1.1
1.1
—
—
—
0
0
17
65
2.64
3.31
1.2
1.1
—
—
—
0
0
19
77
2.50
3.31
1.5
1.3
0.92
0.42
u/ml
0.36
13
39
22
96
2.32
3.28
1.1
1.1
—
—
—
0
0
6
7
8.62
3.26
3.0
3.3
2.45
3.79
mg/l
—
6
7
37
199
1.89
3.24
1.7
1.3
—
—
—
0
0
18
72
2.53
3.22
2.3
1.2
—
—
—
0
0
42
237
1.81
3.18
1.6
1.2
—
43.54
—
0
5
18
73
2.49
3.14
2.3
1.2
—
—
—
0
0
15
56
2.71
3.07
1.5
1.1
1.04
1.05
u/l
—
7
26
21
93
2.29
3.05
1.7
1.5
—
—
—
0
0
21
94
2.26
2.98
1.7
1.5
—
—
—
0
0
21
94
2.26
2.98
1.7
1.5
—
—
—
0
0
17
69
2.49
2.97
1.4
1.5
—
—
—
0
0
20
88
2.30
2.95
1.1
1.1
—
—
—
0
0
61
392
1.59
2.90
1.7
1.4
—
—
—
0
0
12
38
3.18
2.85
1.6
1.1
9.33
14.27
u/l
0.81
12
33
64
420
1.56
2.80
1.9
1.6
—
—
—
0
0
15
59
2.57
2.79
1.7
1.5
—
—
—
0
0
24
117
2.08
2.79
1.3
1.3
—
—
—
0
0
12
39
3.10
2.77
1.6
1.1
52.83
73.29
u/l
0.86
12
34
172
1357
1.33
2.75
2.6
2.7
2.42
2.43
mmol/l
0.99
152
1227
189
1512
1.31
2.74
1.7
1.6
147929403.34
29128866.65
pmol/l
0.75
169
1308
17
73
2.35
2.66
1.5
1.2
76.41
53.94
u/l
0.82
17
66
10
30
3.36
2.60
3.8
3.4
0.65
0.61
mmol/l
—
10
30
659
6118
1.25
2.57
4.4
3.3
54.59
43.90
u/l
1.78
636
5859
36
208
1.76
2.57
3.0
2.4
0.00
0.00
g/l
-0.00
31
182
11
36
3.08
2.57
4.1
2.0
54.09
80.33
ug/l
0.52
11
36
136
1049
1.35
2.54
1.8
1.6
1238.55
1143.48
nmol/l
0.49
107
821
11
37
3.00
2.49
1.1
1.4
—
—
—
0
0
11
37
3.00
2.49
1.1
1.4
—
—
—
0
0
8
21
3.83
2.46
1.1
3.9
3.75
4.85
ug/l
—
8
21
16
70
2.31
2.42
6.8
8.2
9.22
6.95
mmol/l
0.43
11
58
29
160
1.84
2.41
3.5
2.4
129.62
131.99
g/l
0.18
21
125
31
175
1.80
2.40
3.4
4.0
1.36
2.14
ratio
0.93
17
101
6
12
5.02
2.40
13.5
4.8
4.12
6.90
mmol/l
—
6
12
9
27
3.35
2.39
2.1
1.3
—
—
—
0
0
81
581
1.43
2.34
1.6
1.4
24.05
21.75
iu/l
0.29
70
492
811
7748
1.31
2.32
5.2
4.5
5.89
5.85
mmol/l
0.32
757
7269
34
200
1.73
2.31
3.3
3.3
0.80
2.47
index
1.80
19
110
83
600
1.42
2.30
3.5
2.6
71.03
73.81
ml/min/173m2
0.23
38
250
14
59
2.39
2.30
1.9
3.0
1152.29
1236.32
mg
0.08
14
59
44
278
1.61
2.29
5.6
4.2
24.31
25.09
mmol/l
0.87
38
266
10
34
2.96
2.28
4.2
3.8
—
35.46
—
0
9
105
793
1.36
2.26
7.1
5.8
—
—
—
0
0
811
7754
1.30
2.26
4.5
4.0
1.34
1.29
mmol/l
1.14
772
7316
857
8258
1.36
2.25
5.9
5.2
2.70
2.78
mmol/l
2.13
820
7843
7
18
3.91
2.25
1.6
1.2
—
—
—
0
0
46
296
1.58
2.23
1.4
1.4
—
—
—
0
0
7
19
3.70
2.15
1.7
1.4
—
—
—
0
0
12
49
2.47
2.11
1.2
1.1
2000.58
1595.45
miu/ml
0.68
12
49
114
883
1.33
2.09
2.6
2.4
13.91
13.57
nmol/l
0.16
104
816
291
2525
1.22
2.08
3.9
2.8
0.01
0.11
estimate
0.74
90
731
11
43
2.58
2.08
3.7
2.9
440.64
665.28
u/ml
0.91
11
43
33
200
1.67
2.04
3.7
4.1
42.02
76.82
mg/l
0.58
28
172
33
200
1.67
2.04
3.7
4.1
64.80
41.11
mg/l
0.36
28
172
849
8190
1.32
2.04
5.3
4.7
4.55
4.67
mmol/l
3.25
819
7803
9
32
2.83
2.00
2.1
1.3
—
—
—
0
0
97
739
1.35
1.99
4.3
3.0
—
—
—
0
0
5
11
4.56
1.94
1.0
1.0
0.00
0.03
u/ml
—
5
6
8
27
2.98
1.94
4.6
1.6
—
—
—
0
0
9
33
2.74
1.93
1.0
2.7
212.56
185.64
u/l
—
9
33
29
173
1.70
1.91
2.8
2.4
24.07
107.74
ug/min
1.89
19
97
18
92
1.97
1.91
1.6
1.2
—
—
—
0
0
388
3488
1.19
1.87
2.0
1.9
1.42
1.39
mmol/l
0.34
328
3032
25
144
1.76
1.86
3.9
1.6
—
—
—
0
0
6
17
3.54
1.84
1.0
1.0
—
—
—
0
0
927
9096
1.61
1.82
34.8
20.8
256.63
253.54
e9/l
0.80
922
8962
52
362
1.46
1.81
1.6
1.4
8.96
8.36
u/l
0.13
39
293
7
23
3.06
1.80
1.0
1.0
—
—
—
0
0
844
8161
1.29
1.78
5.2
4.6
1.41
1.43
mmol/l
0.85
810
7739
927
9102
1.59
1.74
34.6
20.8
4.56
4.58
e12/l
0.64
919
8955
927
9102
1.59
1.74
35.4
21.4
45.87
41.52
%
0.44
921
9036
54
382
1.44
1.74
1.4
1.4
—
—
—
0
0
8
30
2.68
1.72
1.9
2.0
—
—
—
0
0
11
48
2.31
1.71
1.2
1.1
—
—
—
0
0
35
228
1.56
1.67
1.2
1.1
—
—
—
0
0
927
9107
1.57
1.67
35.0
21.0
137.33
137.86
g/l
0.53
922
9046
8
31
2.59
1.66
1.5
1.2
—
—
—
0
0
56
403
1.41
1.65
5.6
3.0
0.55
0.62
%
1.18
56
403
25
151
1.67
1.61
5.1
3.5
13.24
8.38
pmol/l
0.40
25
151
282
2496
1.18
1.59
5.1
4.8
1.85
2.10
ug/l
0.43
258
2283
11
50
2.21
1.57
1.5
1.7
—
1020533.17
iu/ml
—
0
6
12
57
2.12
1.55
1.3
1.3
0.51
0.55
ratio
—
6
32
5
15
3.34
1.52
3.2
4.1
44.60
41.00
u/l
—
5
15
7
27
2.60
1.51
2.4
1.2
—
—
—
0
0
33
218
1.53
1.50
1.5
1.5
288.02
286.22
ug/g
0.02
16
128
42
293
1.45
1.48
1.8
1.3
—
—
—
0
0
9
37
2.45
1.48
2.0
1.6
—
—
—
0
0
9
37
2.45
1.48
2.0
1.6
—
—
—
0
0
9
37
2.45
1.48
2.0
1.6
—
—
—
0
0
9
37
2.45
1.48
2.0
1.6
—
—
—
0
0
38
260
1.48
1.48
1.6
1.1
2.55
4.23
—
6
45
7
28
2.51
1.45
1.9
1.3
163.29
60.00
nmol/24h
—
7
28
44
312
1.43
1.43
1.8
1.6
—
—
—
0
0
25
157
1.61
1.41
4.1
3.8
14.26
27.73
mg/l
3.05
17
112
34
230
1.50
1.40
1.2
1.1
—
—
—
0
0
5
17
2.95
1.36
1.6
1.3
—
—
—
0
0
24
151
1.60
1.36
1.3
1.2
3.22
3.82
u/ml
—
9
65
98
796
1.26
1.31
3.8
2.6
34.31
98.50
u/l
0.55
87
680
18
106
1.71
1.30
1.8
1.4
0.52
0.61
nmol/l
0.66
18
101
5
18
2.79
1.28
1.2
1.1
110.20
98.28
%
—
5
18
37
261
1.43
1.26
1.2
1.1
0.95
2.97
u/ml
1.70
19
144
36
253
1.44
1.26
1.8
2.0
5.21
4.37
iu/l
0.23
13
100
17
100
1.71
1.24
4.6
1.6
—
—
—
0
0
12
63
1.92
1.23
4.8
1.9
—
—
—
0
0
45
333
1.37
1.19
1.4
1.7
14.95
8.01
u/ml
—
8
91
10
51
1.97
1.11
1.2
1.5
34038.00
16098.41
e6/l
—
5
22
7
137
0.51
1.10
1.4
1.2
—
—
—
0
0
5
21
2.39
1.09
1.2
1.1
—
—
—
0
0
5
21
2.39
1.09
1.2
1.2
—
—
—
0
0
5
21
2.39
1.09
2.0
1.3
—
—
—
0
0
5
21
2.39
1.09
2.0
1.1
—
—
—
0
0
222
1989
1.15
1.06
4.5
4.0
21.24
21.27
%
0.01
92
849
14
82
1.72
1.05
1.1
1.1
—
—
—
0
0
14
82
1.72
1.05
1.2
1.3
—
88.20
—
0
5
9
46
1.97
1.03
2.0
1.5
2.61
4.87
u/l
—
9
36
45
343
1.33
1.01
2.6
2.9
1.02
1.02
ratio
1.91
38
317
9
48
1.88
1.00
1.0
1.1
174.97
182.50
iu/ml
—
9
48
80
658
1.24
1.00
3.4
4.8
3.37
28.18
ug/l
1.24
61
532
18
115
1.58
1.00
1.1
1.1
104.33
97.84
%
0.57
18
106
31
223
1.40
0.99
4.4
4.1
1.27
1.37
mmol/l
0.29
31
216
42
318
1.34
0.99
2.3
2.4
98.29
93.18
%
1.08
42
306
7
37
1.90
0.94
1.1
1.1
118.94
34.67
u/ml
—
7
37
22
150
1.48
0.93
1.1
1.1
118.55
116.85
%
0.10
22
137
23
159
1.46
0.92
1.3
1.2
1.25
3.41
u/ml
1.01
12
59
6
28
2.15
0.91
1.5
1.2
8.98
9.26
ug/l
—
6
28
12
71
1.70
0.89
1.5
1.5
—
—
—
0
0
8
43
1.87
0.87
1.1
1.1
—
—
—
0
0
27
195
1.40
0.87
1.2
1.6
3.17
14.66
e6/l
1.42
18
143
11
64
1.73
0.86
1.4
1.4
72.36
75.94
umol/l
0.30
11
64
10
57
1.76
0.84
1.0
1.2
—
—
—
0
0
180
1618
1.14
0.83
2.3
2.2
—
—
—
0
0
37
284
1.31
0.83
2.5
2.6
172.78
179.92
%
0.18
37
273
167
1494
1.14
0.83
2.3
2.1
—
—
—
0
0
13
81
1.61
0.81
4.1
2.2
17.25
18.72
mg/l
—
8
35
59
484
1.23
0.79
1.5
1.3
—
—
—
0
0
11
174
0.63
0.77
1.2
1.2
—
—
—
0
0
27
200
1.36
0.77
1.3
1.6
141.45
1028.25
e6/l
0.69
20
154
6
34
1.77
0.76
2.0
1.6
—
—
—
0
0
6
34
1.77
0.76
1.0
1.4
—
—
—
0
0
6
34
1.77
0.76
1.0
1.4
—
—
—
0
0
169
1525
1.13
0.74
3.1
2.9
0.59
0.73
ug/l
2.26
101
883
104
907
1.16
0.74
4.6
4.4
32.17
31.20
%
0.42
83
640
15
100
1.51
0.73
4.3
2.2
—
—
—
0
0
12
76
1.59
0.72
1.1
1.1
103.50
115.00
pmol/l
0.55
12
76
5
26
1.93
0.70
3.2
1.7
100.40
107.47
ng/l
—
5
26
65
548
1.20
0.69
6.9
3.7
1.23
1.22
mmol/l
0.52
53
477
10
61
1.65
0.68
2.6
2.7
—
—
—
0
0
18
127
1.43
0.68
3.9
2.1
7.36
5.24
mmol/24h
1.31
18
114
59
495
1.20
0.66
1.1
1.0
—
—
—
0
0
21
154
1.37
0.65
3.4
2.4
6.21
6.46
umol/l
0.04
15
114
5
29
1.73
0.64
1.2
1.1
—
—
—
0
0
105
931
1.14
0.62
2.2
2.1
—
—
—
0
0
145
1314
1.12
0.61
1.8
1.8
1.50
1.46
%
0.29
130
1188
21
157
1.35
0.59
1.1
1.1
—
—
—
0
0
35
431
0.80
0.59
1.1
1.1
0.77
0.66
ratio
—
6
45
37
300
1.24
0.59
1.6
1.6
—
—
—
0
0
29
228
1.28
0.59
1.2
1.1
1.75
5.66
u/ml
1.83
12
130
5
87
0.57
0.56
1.6
1.2
—
—
—
0
0
11
73
1.51
0.56
1.9
1.5
—
—
—
0
0
20
150
1.34
0.56
1.9
1.8
—
—
—
0
0
25
195
1.29
0.54
1.1
1.5
0.72
0.39
nmol/l
0.43
18
158
156
1431
1.11
0.54
1.8
1.6
—
—
—
0
0
731
7160
1.09
0.52
27.3
16.9
13.57
13.42
%
2.57
726
7088
19
144
1.33
0.51
1.2
1.1
0.86
2.54
eliau/ml
—
8
65
27
216
1.26
0.50
1.8
1.6
—
—
—
0
0
18
137
1.32
0.47
4.5
6.7
348.05
364.93
umol/l
0.16
18
124
53
460
1.16
0.45
1.9
1.7
300.72
305.76
mu/l
0.04
46
423
14
186
0.75
0.44
2.0
1.8
—
—
—
0
0
20
157
1.28
0.43
1.1
1.1
112.63
101.35
iu/ml
—
8
35
21
166
1.27
0.43
1.2
1.4
16.66
20.14
u/l
0.26
14
140
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
31
1.62
0.43
1.2
1.1
103.40
117.13
%
—
5
31
0
16
0.00
0.41
0.0
1.3
—
191.36
—
0
11
5
34
1.47
0.40
1.6
1.2
—
—
—
0
0
55
485
1.14
0.39
1.8
1.7
0.24
0.33
mg/l
0.77
27
231
39
452
0.86
0.39
1.1
1.1
1.45
1.52
g/l
0.83
39
452
22
180
1.23
0.36
1.5
1.1
8.60
12.53
au/ml
—
6
57
6
42
1.43
0.35
1.0
1.7
—
77.86
%
—
0
7
26
218
1.20
0.34
1.3
1.1
1.33
1.54
u/ml
0.09
12
110
6
44
1.37
0.34
2.2
1.1
—
—
—
0
0
15
118
1.28
0.33
1.0
1.1
—
—
—
0
0
7
52
1.35
0.31
4.9
1.5
—
—
—
0
0
8
67
1.20
0.26
1.3
1.1
1.00
1.06
ratio
—
8
58
17
203
0.83
0.26
5.4
2.1
0.79
0.90
nmol/l
0.37
17
174
34
301
1.13
0.25
2.0
1.9
218.32
211.71
pmol/l
0.09
34
286
42
466
0.90
0.25
1.1
1.1
0.92
0.89
g/l
0.28
42
466
83
774
1.08
0.24
2.3
2.0
—
—
—
0
0
12
96
1.25
0.24
1.6
1.1
17.43
15.58
u/ml
—
7
43
11
88
1.25
0.22
1.1
1.0
—
—
—
0
0
5
40
1.25
0.22
3.2
2.5
22.46
218.22
ug/l
—
5
35
25
219
1.15
0.22
1.5
1.5
69.80
55.77
ug/l
0.75
25
219
5
41
1.22
0.22
5.8
1.5
—
—
—
0
0
5
42
1.19
0.21
5.8
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
0
12
0.00
0.21
0.0
2.7
—
0.67
—
0
12
5
43
1.16
0.21
1.0
1.0
41.36
34.36
ng/l
—
5
26
5
43
1.16
0.21
1.0
1.0
301.60
262.34
ng/l
—
5
29
5
43
1.16
0.21
1.0
1.0
550.40
673.73
ng/l
—
5
30
0
13
0.00
0.21
0.0
1.4
—
5.95
—
0
13
43
393
1.10
0.20
1.6
1.9
—
—
—
0
0
6
49
1.23
0.20
5.3
1.4
—
—
—
0
0
6
49
1.23
0.20
1.0
1.2
—
—
—
0
0
39
426
0.91
0.19
1.6
1.4
—
—
—
0
0
7
58
1.21
0.18
1.4
1.2
6.43
7.69
mm/h
—
7
58
32
352
0.91
0.18
1.3
1.4
—
—
—
0
0
22
195
1.13
0.17
1.2
1.2
—
—
—
0
0
7
62
1.13
0.17
1.6
1.3
—
—
—
0
0
6
76
0.79
0.15
1.0
1.4
149.82
167.89
pmol/l
—
6
76
33
354
0.93
0.12
1.3
1.4
1.10
1.21
ratio
0.30
23
221
33
354
0.93
0.12
1.3
1.4
1.13
1.14
ratio
0.03
23
221
33
354
0.93
0.12
1.3
1.4
0.82
0.94
ratio
1.95
23
221
88
913
0.96
0.11
1.6
1.7
3.39
3.47
mmol/l
0.31
56
640
44
417
1.06
0.10
1.4
1.3
243.51
237.52
miu/ml
0.03
20
212
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
44
1.14
0.10
1.2
1.2
—
—
—
0
0
5
48
1.04
0.09
1.6
4.3
0.60
0.92
index
—
5
48
6
57
1.05
0.08
1.2
1.2
—
—
—
0
0
6
75
0.80
0.07
2.0
2.4
1.21
1.19
mmol/l
—
6
75
119
1208
0.98
0.04
1.7
1.9
3.63
3.51
ratio
0.47
88
928
42
408
1.03
0.04
1.8
1.7
7.63
3.50
mg/l
0.67
35
295
66
648
1.02
0.03
1.5
1.6
895.88
977.89
mu/l
0.52
55
533
15
146
1.03
0.00
1.2
1.1
—
1.64
—
0
8
13
132
0.98
0.00
3.1
3.1
6.74
7.40
mmol/l
0.30
13
127
27
265
1.02
0.00
1.6
1.7
—
—
—
0
0
15
155
0.97
0.00
1.8
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
1.60
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
75
0.93
-0.00
1.9
2.4
106.00
105.80
mmol/l
—
7
75
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
13.58
—
0
9
Mortality – FinRegistry
↥Association
Association between endpoint AB1_OTHER_SUPERF_MYCOSIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_OTHER_SUPERF_MYCOSIS | 1.458 [1.17, 1.82] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.101 |
During the follow-up period (1.1.1998 — 31.12.2019), 162 out of 1804 females with AB1_OTHER_SUPERF_MYCOSIS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_OTHER_SUPERF_MYCOSIS | 1.789 [1.46, 2.2] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.005 |
During the follow-up period (1.1.1998 — 31.12.2019), 270 out of 1925 males with AB1_OTHER_SUPERF_MYCOSIS died.
Mortality risk
Mortality risk for people of age
years, who have AB1_OTHER_SUPERF_MYCOSIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.135% | 0.398% |
| 5 | 0.8% | 2.169% |
| 10 | 2.085% | 5.0% |
| 15 | 4.018% | 9.478% |
| 20 | 7.086% | 15.894% |
Relationships between endpoints
↥Index endpoint: AB1_OTHER_SUPERF_MYCOSIS – Other superficial mycoses
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data